The Effect of Laser Therapy on Visual Acuity in Patients with PDR, BRVO and CRVO

Authors

MR Ansari1,*, F Sheikhi1, F Daneshgar1, E Ghaderi1
1Iran
*Corresponding Author: Corresponding author: MR Ansari, Iran, E-mail: Email: [email protected]

Journal of Kermanshah University of Medical Sciences:Vol. 10, issue 1; e81703
Published online:Jun 19, 2006
Article type:Research Article
Received:Nov 06, 2004
Accepted:Mar 14, 2006
How to Cite:Ansari M, Sheikhi F, Daneshgar F, Ghaderi E. The Effect of Laser Therapy on Visual Acuity in Patients with PDR, BRVO and CRVO. J Kermanshah Univ Med Sci. 2006;10(1):e81703. doi:

Abstract

Introduction: Laser therapy Prevents complications of proliferative diabetic retinopathy, central retinal vein occlusion and branch retinal vein occlusion but its effect on visual acuity is controversial. This study evaluated the effect of laser on visual acuity in these patients.

Materials and Methods: This interventional study conducted as before–after in which 96 patients (133 eyes) were evaluated. After laser therapy the patients were followen up (3 weeks to six months) and visual acuity based on Snellen chart were assessed.

Results: 101 proliferative diabetic retinopathy, 16 branch retinal vein occlusion and 16 central retinal vein occlusion inflicted eyes were evaluated. This study contained 114 eyes of diabetic patients, 84 eyes of HTN patients and 46 eyes of hyperlipidemic patients. The means of corrected visual loss in PDR patients was 31.81+34.37 and 37.67 + 37.01 percent before and after laser therapy (p<0.05).

Conclusion: It was concluded from this study that laser therapy in proliferative diabetic retinopathy patients does not cause visual improvement in short time.

Fulltext

The full text of this article is available on PDF

Copyright

© 2006, Journal of Kermanshah University of Medical Sciences. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

28
Oct
2012

Comparing the Effect of Interavitreal Bevacizumab in Visual Acuity of Ischemic and Non-Ischemic Diabetic Macular Edema

Farzaneh Ghasemzadeh,
Reza Jafari

Ghasemzadeh F, Jafari R. Comparing the Effect of Interavitreal Bevacizumab in Visual Acuity of Ischemic and Non-Ischemic Diabetic Macular Edema. Zahedan J Res Med Sci. 2013;15(2):e93089. doi:

15
Dec
2021
Association of Microalbuminuria and Bevacizumab Therapy Outcomes in Diabetic Retinopathy Patients

Association of Microalbuminuria and Bevacizumab Therapy Outcomes in Diabetic Retinopathy Patients

Seyed Ahmad Rasoulinejad

Rasoulinejad SA. Association of Microalbuminuria and Bevacizumab Therapy Outcomes in Diabetic Retinopathy Patients. Nephro-Urol Mon. 2021;14(1):e118972. doi: https://doi.org/10.5812/numonthly.118972

31
Dec
2005

Risk factors of diabetic retinopathy in patients referred to Bouali eye center

M Mazarei

Mazarei M. Risk factors of diabetic retinopathy in patients referred to Bouali eye center. J Inflamm Dis. 2024;9(3):e155141. doi:

24
Aug
2015

Role of Serum Levels of Vascular Endothelial Growth Factor and Its Receptor in Retinopathy of Prematurity

Binita Goswami,
Monika Goyal,
Sarita Beri,
Rajiv Garg,
Arvind Saili,
Anju Jain

Goswami B, Goyal M, Beri S, Garg R, Saili A, et al. Role of Serum Levels of Vascular Endothelial Growth Factor and Its Receptor in Retinopathy of Prematurity. Inn J Pediatr. 2015;25(4):e2373. doi: https://doi.org/10.5812/ijp.2373

20
May
2013

Prevalence of Preventable Causes of Low Vision in Different Ages and Genders

Mohsen Akhgary,
Mohammad Ghassemi - Broumand,
Mohammad Aghazadeh - Amiri,
Mehdi Tabatabaee

Akhgary M, Ghassemi - Broumand M, Aghazadeh - Amiri M, Tabatabaee M. Prevalence of Preventable Causes of Low Vision in Different Ages and Genders. Zahedan J Res Med Sci. 2013;16(1):. doi:

More by these authors

MR AnsariPubMedScholar
F SheikhiPubMedScholar
F DaneshgarPubMedScholar
E GhaderiPubMedScholar
Share
Cited by
Metrics